×
About 6,250 results

ALLMedicine™ Glomerular Filtration Rate (gfr) Center

Research & Reviews  2,074 results

Clinical impact of blood urea nitrogen, regardless of renal function, in heart failure ...
https://doi.org/10.1016/j.ijcard.2022.06.061
International Journal of Cardiology; Yano M, Nishino M et. al.

Jul 2nd, 2022 - Blood urea nitrogen (BUN) reflects decreased glomerular filtration rate (GFR). The effect of BUN on clinical outcomes, excluding the impact of GFR, in heart failure with preserved ejection fraction (HFpEF) patients remains unknown. We enrolled HFp...

Renoprotective effects of empagliflozin in type 1 and type 2 models of diabetic nephrop...
https://doi.org/10.1007/s11357-022-00610-7 10.1053/j.ajkd.2020.08.003 10.1056/NEJMoa1515920 10.1161/CIR.0000000000000950 10.1042/CS20171298 10.1016/j.cmet.2017.04.011 10.1152/ajpheart.00438.2021 10.1007/s00125-016-4157-3 10.1152/ajprenal.2001.280.1.F10 10.1074/jbc.M117.779520 10.1146/annurev-physiol-020911-153333 10.1097/MNH.0000000000000584 10.1161/CIRCULATIONAHA.119.044183 10.1056/NEJMoa1504720 10.1056/NEJMoa2030186 10.1056/NEJMc1712572 10.1002/ejhf.1432 10.1056/NEJMoa1811744 10.1161/CIRCULATIONAHA.120.048740 10.1007/s00125-018-4654-7 10.1146/annurev-physiol-031620-095920 10.1124/jpet.113.203869 10.1152/ajpregu.00382.2012 10.1152/ajprenal.00145.2014 10.1016/j.pcad.2020.04.003 10.1152/ajprenal.00520.2013 10.1161/CIRCULATIONAHA.118.037076 10.1124/jpet.120.000408 10.1681/ASN.2019080784 10.1124/jpet.119.258954 10.1007/s11357-020-00179-z 10.2337/diabetes.53.3.735 10.1007/s11357-020-00233-w 10.1152/ajprenal.00184.2018 10.1186/s12933-014-0148-1 10.1056/NEJMc1600140 10.1056/NEJMoa2024816 10.1152/ajprenal.00565.2018 10.1152/ajprenal.00551.2017 10.1152/ajprenal.00273.2014 10.1097/MNH.0000000000000088 10.1161/CIRCULATIONAHA.118.037418 10.1161/CIRCULATIONAHA.113.005081 10.1152/ajprenal.00043.2017 10.1046/j.1523-1755.2001.00482.x 10.1016/j.kint.2019.09.013 10.1161/HYPERTENSIONAHA.118.10269 10.2337/dc14-1096
GeroScience Williams JM, Murphy SR et. al.

Jun 30th, 2022 - Diabetes, hypertension, and aging are major contributors to cardiovascular and chronic kidney disease (CKD). Sodium/glucose cotransporter 2 (SGLT2) inhibitors have become a preferred treatment for type II diabetic patients since they have cardiore...

Robot-assisted versus conventional laparoscopic partial nephrectomy for renal hilar tum...
https://doi.org/10.1111/iju.14968
International Journal of Urology : Official Journal of Th... Bao X, Dong W et. al.

Jun 29th, 2022 - To determine whether robot-assisted laparoscopic partial nephrectomy (RALPN) can benefit patients in terms of functional recovery in the treatment of renal hilar tumors compared to conventional laparoscopic partial nephrectomy (CLPN). Between Janu...

see more →

Drugs  8 results see all →

Clinicaltrials.gov  255 results

Viral Load Guided Immunosuppression After Lung Transplantation
https://clinicaltrials.gov/ct2/show/NCT04198506

Jun 24th, 2022 - The VIGILung study is an open-label, randomized, multicenter trial in lung transplant recipients to investigate the safety and efficacy of personalized immunosuppression guided by DNA monitoring of Torque-Teno-Virus (TTV). The aim of the study is ...

Pharmacokinetics of Morphine and Oxycodone in Frail Elderly Undergoing Cardiac Surgery
https://clinicaltrials.gov/ct2/show/NCT04696445

Jun 23rd, 2022 - Postoperative pain after cardiac surgery in elderly patients is common and leads to postoperative complications. Opioids play an important role in treatment of postoperative pain after cardiac surgery. In frail elderly after cardiac surgery howeve...

Canagliflozin Targeting Vascular Inflammation
https://clinicaltrials.gov/ct2/show/NCT05427084

Jun 22nd, 2022 - CANTOR SING is a pilot single center double blinded randomized study to determine the effect of targeted anti-inflammation therapy using canagliflozin, on aortic inflammation using imaging, i.e. ascending aortic FDG uptake. The current proposal us...

Mechanisms of Diuretic Resistance in Heart Failure
https://clinicaltrials.gov/ct2/show/NCT05323487

Jun 10th, 2022 - The protocol will begin with pre-study determination of diuretic response at the screening visit via administration of 10 mg IV bumetanide infused over 1 hour and measuring peak Fractional Excretion of Sodium (FENa), 1-hour post completion of infu...

Clinical Trial To Evaluate Safety And Efficacy Of US-APR2020 In Subjects With Chronic Kidney Disease Stage IV
https://clinicaltrials.gov/ct2/show/NCT04913272

Jun 3rd, 2022 - Kidney diseases are a global public health problem that affects over 200 million people worldwide. It is estimated that about 30 million adults in the United States have Chronic Kidney Disease (CKD) and most are undiagnosed. In addition, CKD repre...

see more →

News  159 results

Mixing BP Meds With NSAID May Be 'Triple Whammy' for Kidneys
https://www.medscape.com/viewarticle/973885

May 12th, 2022 - Patients who mix a diuretic and renin-angiotensin system (RAS) inhibitor with a nonsteroidal anti-inflammatory drug (NSAID) could face a higher risk of developing acute kidney injury (AKI), a new analysis confirms. The study also looked at risk fa...

Fast Five Quiz: Chronic Kidney Disease (CKD) Hyperphosphatemia
https://reference.medscape.com/viewarticle/948765

Apr 26th, 2021 - Hyperphosphatemia or abnormally high serum phosphate levels, has been identified as a key factor associated with cardiovascular complications and increased mortality risk among patients with chronic kidney disease (CKD). Hyperphosphatemia is a lat...

Chronic Kidney Disease Associated With Increased Risk of Renal and Urothelial Cancers
https://www.onclive.com/view/chronic-kidney-disease-associated-with-increased-risk-of-renal-and-urothelial-cancers

Dec 20th, 2020 - Will Lowrance, MD, MPH Assistant Professor, Surgery Huntsman Cancer Institute at the University of Utah Does renal disease increase one’s risk of developing cancer? We know there is a well-studied association between end-stage rena...

Adjuvant Chemotherapy Shows Strong Benefit in Upper Tract Urothelial Carcinoma
https://www.onclive.com/view/adjuvant-chemotherapy-shows-strong-benefit-in-upper-tract-urothelial-carcinoma

Dec 4th, 2020 - Alison J. Birtle, MD, MBBS, MRCP, FRCR Adjuvant platinum-based chemotherapy reduced the risk of disease recurrence or death by 55% in patients with upper tract urothelial carcinoma (UTUC), according to findings from the phase III POUT trial that ...

Belimumab Shows Benefits for Lupus Nephritis
https://www.medpagetoday.com/rheumatology/lupus/88662

Sep 16th, 2020 - Patients with lupus nephritis who received belimumab (Benlysta) plus standard therapy were significantly more likely to have a renal response at 2 years than those given placebo plus standard care, a large randomized trial found. At week 104, 43% ...

see more →

Patient Education  4 results see all →